125 related articles for article (PubMed ID: 37541419)
1. Reanalysis of single-cell data reveals macrophage subsets associated with the immunotherapy response and prognosis of patients with endometrial cancer.
Wu Q; Jiang G; Sun Y; Li B
Exp Cell Res; 2023 Sep; 430(2):113736. PubMed ID: 37541419
[TBL] [Abstract][Full Text] [Related]
2. Protein-based prognostic signature for predicting the survival and immunotherapeutic efficiency of endometrial carcinoma.
Lai J; Xu T; Yang H
BMC Cancer; 2022 Mar; 22(1):325. PubMed ID: 35337291
[TBL] [Abstract][Full Text] [Related]
3. Identification of an immune checkpoint gene signature that accurately predicts prognosis and immunotherapy response in endometrial carcinoma.
Li S; Dong C; Chen J; Gao X; Xie X; Zhang X
Aging (Albany NY); 2021 Jun; 13(12):16696-16712. PubMed ID: 34158412
[TBL] [Abstract][Full Text] [Related]
4. Identification of EMT-associated LncRNA Signature for Predicting the Prognosis of Patients with Endometrial Cancer.
Shu W; Wang Z; Zhang W; Zhang J; Zhao R; Yu Z; Dong K; Wang H
Comb Chem High Throughput Screen; 2023; 26(8):1488-1502. PubMed ID: 36200154
[TBL] [Abstract][Full Text] [Related]
5. Landscape of PCOS co-expression gene and its role in predicting prognosis and assisting immunotherapy in endometrial cancer.
Zhang Y; Hu Y; Yu J; Xie X; Jiang F; Wu C
J Ovarian Res; 2023 Jul; 16(1):129. PubMed ID: 37393293
[TBL] [Abstract][Full Text] [Related]
6. Chemokines mRNA expression in relation to the Macrophage Migration Inhibitory Factor (MIF) mRNA and Vascular Endothelial Growth Factor (VEGF) mRNA expression in the microenvironment of endometrial cancer tissue and normal endometrium: a pilot study.
Giannice R; Erreni M; Allavena P; Buscaglia M; Tozzi R
Cytokine; 2013 Nov; 64(2):509-15. PubMed ID: 23985752
[TBL] [Abstract][Full Text] [Related]
7. A novel risk prediction model of pyroptosis-related genes for the prognosis and immunotherapy response of endometrial cancer.
Liu ZS; Jing CL
Eur Rev Med Pharmacol Sci; 2022 Apr; 26(7):2259-2278. PubMed ID: 35442481
[TBL] [Abstract][Full Text] [Related]
8. A novel five-gene metabolism-related risk signature for predicting prognosis and immune infiltration in endometrial cancer: A TCGA data mining.
Huang H; Cai X; Lin J; Wu Q; Zhang K; Lin Y; Liu B; Lin J
Comput Biol Med; 2023 Mar; 155():106632. PubMed ID: 36805217
[TBL] [Abstract][Full Text] [Related]
9. Identification of
Zhu Y; Lin X; Zang Y; Yang Q
J Healthc Eng; 2021; 2021():4372373. PubMed ID: 34970423
[TBL] [Abstract][Full Text] [Related]
10. Identification of immunogenic cell death-related subtypes used for predicting survival and immunotherapy of endometrial carcinoma through a bioinformatics analysis.
Liu Z; Luo Y; Su L; Hu X
Medicine (Baltimore); 2023 Aug; 102(31):e34571. PubMed ID: 37543760
[TBL] [Abstract][Full Text] [Related]
11. Prognostic evaluation of the novel blueprint of DNA methylation sites by integrating bulk RNA-sequencing and methylation modification data in endometrial cancer.
Zhou H; Zhang Y; Jin J; Shen K; Yang Y; Lao P
J Gene Med; 2024 Jan; 26(1):e3638. PubMed ID: 38011892
[TBL] [Abstract][Full Text] [Related]
12. Lactate metabolism-related genes to predict the clinical outcome and molecular characteristics of endometrial cancer.
Shi R; Li H; Wei S; Yu Z; Zhang J; Zhang Q; Zhou T; Yao Y; Zhang Q; Zhang T; Wang H
BMC Cancer; 2023 May; 23(1):491. PubMed ID: 37259038
[TBL] [Abstract][Full Text] [Related]
13. Establishing a Prognostic Signature Based on Epithelial-Mesenchymal Transition-Related Genes for Endometrial Cancer Patients.
Liu J; Cui G; Shen S; Gao F; Zhu H; Xu Y
Front Immunol; 2021; 12():805883. PubMed ID: 35095892
[TBL] [Abstract][Full Text] [Related]
14. Construction of a microenvironment immune gene model for predicting the prognosis of endometrial cancer.
Wang Y; Zhang J; Zhou Y; Li Z; Lv D; Liu Q
BMC Cancer; 2021 Nov; 21(1):1203. PubMed ID: 34763648
[TBL] [Abstract][Full Text] [Related]
15. Development and Validation of a Five-immune Gene Pair Signature in Endometrial Carcinoma.
Li N; Yu K; Lin Z; Zeng D
Comb Chem High Throughput Screen; 2021; 24(2):233-245. PubMed ID: 32729416
[TBL] [Abstract][Full Text] [Related]
16. An immune-related pseudogene signature to improve prognosis prediction of endometrial carcinoma patients.
Tang S; Zhuge Y
Biomed Eng Online; 2021 Jun; 20(1):64. PubMed ID: 34193185
[TBL] [Abstract][Full Text] [Related]
17. The macrophage-associated prognostic gene ANXA5 promotes immunotherapy resistance in gastric cancer through angiogenesis.
Hong Z; Wen P; Wang K; Wei X; Xie W; Rao S; Chen X; Hou J; Zhuo H
BMC Cancer; 2024 Jan; 24(1):141. PubMed ID: 38287304
[TBL] [Abstract][Full Text] [Related]
18. Integrated analysis of single-cell and bulk RNA-sequencing identifies a signature based on T-cell marker genes to predict prognosis and immunotherapy response in bladder cancer.
Shi X; Dong A; Yang Y; Zheng G; Wang N; Yang C; Wang Y; Lu J; Jia X
J Cancer Res Clin Oncol; 2023 Sep; 149(12):9733-9746. PubMed ID: 37244876
[TBL] [Abstract][Full Text] [Related]
19. ImmuneScore of eight-gene signature predicts prognosis and survival in patients with endometrial cancer.
Gu J; Wang Z; Wang BO; Ma X
Front Oncol; 2023; 13():1097015. PubMed ID: 36937436
[TBL] [Abstract][Full Text] [Related]
20. BCHE as a Prognostic Biomarker in Endometrial Cancer and Its Correlation with Immunity.
Liu J; Tian T; Liu X; Cui Z
J Immunol Res; 2022; 2022():6051092. PubMed ID: 35915658
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
